Cargando…
Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine
Introduction: Inflammatory bowel diseases (IBDs) are lifelong conditions causing relapsing inflammation of the intestine. In the absence of a cure, clinical management of IBDs is extremely challenging since they present with a wide range of phenotypes and disease behaviors. Hence, there is an urgent...
Autores principales: | Giachero, Federica, Jenke, Andreas, Zilbauer, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903817/ https://www.ncbi.nlm.nih.gov/pubmed/34142929 http://dx.doi.org/10.1080/1744666X.2021.1945442 |
Ejemplares similares
-
Differential Expression of Mucosal Trefoil Factors and Mucins in Pediatric Inflammatory Bowel Diseases
por: Hensel, Kai O., et al.
Publicado: (2014) -
Differential expression of mucosal trefoil factors and mucins in pediatric inflammatory bowel diseases
por: Jenke, Andreas C, et al.
Publicado: (2015) -
Expression of Human Beta-Defensins in Children with Chronic Inflammatory Bowel Disease
por: Zilbauer, Matthias, et al.
Publicado: (2010) -
Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020) -
Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy
por: Gasparetto, Marco, et al.
Publicado: (2016)